Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies
Primary biliary cholangitis and primary sclerosing cholangitis are rare diseases affecting the bile ducts and the liver. The limited knowledge of their pathogenesis leads to limited therapeutic options. Nevertheless, the landscape of novel therapies for these cholangiopathies is now rapidly changing...
Main Authors: | Alessio Gerussi, Daphne D’Amato, Laura Cristoferi, Sarah Elizabeth O’Donnell, Marco Carbone, Pietro Invernizzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119322604 |
Similar Items
-
New Therapeutic Targets in Autoimmune Cholangiopathies
by: Alessio Gerussi, et al.
Published: (2020-04-01) -
Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial
by: Ruth Bolier, et al.
Published: (2017-05-01) -
The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities
by: Marta Mazzetti, et al.
Published: (2021-04-01) -
The Gut-Liver Axis in Cholestatic Liver Diseases
by: Andreas Blesl, et al.
Published: (2021-03-01) -
Management of Autoimmune Liver Diseases after Liver Transplantation
by: Romelia Barba Bernal, et al.
Published: (2021-05-01)